Smooth Drug Development January 2021 News Release

We are happy to present our new signed projects:

• Contract for CTA submission of the final report with a new Sponsor.
• Agreement for a bioequivalence study (INN: Dutasteride + Tamsulosin).

 

Clinical and Scientific Departments News:  

• All initiation visits were performed in the phase III Acetylcysteine trial.
• Initiation visits were performed in a III phase trial with Nimesulide, gel.
• Clinical study report in Paracetamol bioequivalence trial was sent to the Sponsor.
• We performed initiation visits in 2 sites in trial with Ethylmethylhydroxypyridine succinate.